Study Comparing Two Stop Smoking Intervention Efficacies

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

620 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-01

Study Completion Date

2018-05-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed study will compare the efficacy of two psychological stop smoking interventions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Staff Stop Smoking Project

NCT04263545

Smoking Cessation

COMPLETED NA

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

NCT06484179

Cancer Smoking

RECRUITING NA

Prevention of Smoking Related Diseases

NCT06451029

Lung Cancer Lung Cancer Screening Smoking Cessation

RECRUITING

Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.

NCT02601521

Smoking Cessation Tobacco Use Disorder

COMPLETED NA

Nicotine Replacement Therapy (NRT) Sampling and Selection to Increase Medication Adherence

NCT03276780

Smoking Cessation

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The proposed study comprises a randomised controlled trial (n = 620) which will compare the efficacy of two psychological stop smoking interventions. Specifically, Allen Carr's Easyway smoking cessation programme comprising one 5/6 hour group session (plus one or two 3 hour booster sessions over the following 3 months for those who require them) and a 1-1 counselling service available via the NHS (comprising one 30 minute session and four weekly follow ups of 10-15 minutes) will be compared. The efficacy of both treatments will be followed up at 4, 12 and 26 weeks after treatment. The evaluation will be compliant with the Russell 6 Standard (which requires, amongst other things, a double blind, randomised design, chemical verification of quit outcomes, and the inclusion of all participants who received treatment in the final analysis). The findings will add to the evidence base around the use of the Allen Carr method, in particular by testing it in non-commercial settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NHS smoking cessation

NHS 1-1 smoking cessation programme. One thirty minute session followed by up to five shorter sessions (approx.10/15minutes) comprising Cognitive Behavioural Therapy/Motivational Interviewing to assist with smoking cessation.

Group Type ACTIVE_COMPARATOR

NHS 1-1 smoking cessation programme.

Intervention Type BEHAVIORAL

Smoking cessation using cognitive behavioural therapy/motivational interviewing

Allen Carr's Easyway smoking cessation

Group smoking cessation programme. One 5/6 hour group session (plus one or two 3 hour booster sessions over the following 3 months for those who require them) comprising of Allen Carr's Easyway method being delivered in a spoken form.

Group Type ACTIVE_COMPARATOR

Group smoking cessation programme

Intervention Type BEHAVIORAL

Smoking cessation using Allen Carr's Easyway method being delivered in a spoken form.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NHS 1-1 smoking cessation programme.

Smoking cessation using cognitive behavioural therapy/motivational interviewing

Intervention Type BEHAVIORAL

Group smoking cessation programme

Smoking cessation using Allen Carr's Easyway method being delivered in a spoken form.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Current smoker Aged over 18 Prepared to be assigned randomly to one of two treatment conditions (NHS standard provision or Allen Carr's Easyway) Intend to quit smoking cigarettes.

Exclusion Criteria

Individuals who would prefer an NHS provided treatment Currently in another RCT or similar research project Have a mental health condition Are pregnant Have a respiratory disease (such as chronic obstructive pulmonary disease or emphysema).

Unable to reach the treatment locations (London South Bank Universities Southwark Campus or SW20) .

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No